NO20092960L - Krystallinsk minocycline base og framgangsmater for framstilling av denne - Google Patents

Krystallinsk minocycline base og framgangsmater for framstilling av denne

Info

Publication number
NO20092960L
NO20092960L NO20092960A NO20092960A NO20092960L NO 20092960 L NO20092960 L NO 20092960L NO 20092960 A NO20092960 A NO 20092960A NO 20092960 A NO20092960 A NO 20092960A NO 20092960 L NO20092960 L NO 20092960L
Authority
NO
Norway
Prior art keywords
minocycline base
processes
preparation
crystalline
crystalline minocycline
Prior art date
Application number
NO20092960A
Other languages
English (en)
Inventor
Zita Mendes
William Heggie
Susana Marto
Jose Rafael Antunes
Original Assignee
Hovione Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovione Int Ltd filed Critical Hovione Int Ltd
Publication of NO20092960L publication Critical patent/NO20092960L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C07C237/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton of a ring being part of a condensed ring system formed by at least four rings, e.g. tetracycline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Oppfinnelsen framskaffer krystallinsk minosyklin-base. Der er særlig framskaffet tre krystallinske polymorfe former av minosyklin, benevnt som form I, form II og form III. Disse er karakterisert ved XRD og IR data. Framgangsmåter for framstilling av de nye polymorfe formene er også framskaffet. For eksempel blir form I framstilt ved å løse og/eller suspendere amorf minosyklin-base i et organisk løsningsmiddel valgt fra etere, etterfulgt av krystallisering fra blandingen.
NO20092960A 2007-02-23 2009-09-04 Krystallinsk minocycline base og framgangsmater for framstilling av denne NO20092960L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT103661A PT103661B (pt) 2007-02-23 2007-02-23 Processo de preparação de minociclina base cristalina
PCT/GB2008/000625 WO2008102161A2 (en) 2007-02-23 2008-02-22 Crystalline minocycline base and processes for its preparation

Publications (1)

Publication Number Publication Date
NO20092960L true NO20092960L (no) 2009-11-20

Family

ID=39432804

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20092960A NO20092960L (no) 2007-02-23 2009-09-04 Krystallinsk minocycline base og framgangsmater for framstilling av denne

Country Status (20)

Country Link
US (2) US8258327B2 (no)
EP (1) EP2125705B1 (no)
JP (4) JP2010519247A (no)
KR (1) KR101391132B1 (no)
CN (1) CN101679218B (no)
AU (1) AU2008217619B2 (no)
BR (2) BRPI0807319B1 (no)
CA (2) CA2835788C (no)
DK (1) DK2125705T3 (no)
ES (1) ES2610434T3 (no)
HU (1) HUE033030T2 (no)
IL (1) IL200544A0 (no)
MX (2) MX2009008980A (no)
NO (1) NO20092960L (no)
NZ (1) NZ579626A (no)
PL (1) PL2125705T3 (no)
PT (1) PT103661B (no)
RU (2) RU2485095C2 (no)
WO (1) WO2008102161A2 (no)
ZA (1) ZA200906517B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
MXPA05004278A (es) 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
PT103661B (pt) 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
PT104350A (pt) 2009-01-23 2010-07-23 Hovione Farmaci Ncia S A Processo de isolamento de tigeciclina
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
PT104644B (pt) 2009-06-26 2012-11-06 Hovione Farmaciencia S A Formulação tópica contendo uma tetraciclina e método de tratamento de infecções cutâneas usando a mesma
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
BR112012007473A2 (pt) 2009-10-02 2019-05-07 Foamix Ltd composições tópicas de tetraciclina e respectivo método de uso
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
PT106063B (pt) 2011-12-19 2017-05-30 Inst Superior Tecnico Minociclina cristalina termorresistente produzida por recristalização com dióxido de carbono
CN104151186B (zh) * 2014-08-11 2016-06-15 重庆福安药业(集团)股份有限公司 替加环素杂质的立体选择性制备方法
PT108223B (pt) 2015-02-13 2018-05-08 Hovione Farm S A Novas formas polimórficas de minociclina base e processos para a sua preparação
BR112017020358A2 (pt) 2015-03-23 2018-07-17 Biopharmx Inc composição farmacêutica de tetraciclina para uso dermatológico
WO2017097891A1 (en) * 2015-12-10 2017-06-15 Sandoz Ag Crystalline eravacycline
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
US12539333B2 (en) 2018-10-29 2026-02-03 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Tetracycline complexes with sustained activity
US20210308154A1 (en) 2020-03-24 2021-10-07 Hovione Scientia Limited Methods and Compositions for Treating Meibomian Gland Dysfunction
WO2022043457A1 (en) 2020-08-27 2022-03-03 Hovione Scientia Limited Methods and compositions for treating rosacea
CN117105812B (zh) * 2023-08-16 2025-09-26 常州市第四制药厂有限公司 一种米诺环素无菌软膏剂及制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US299111A (en) * 1884-05-27 Process of and apparatus
US3148212A (en) * 1961-12-22 1964-09-08 American Cyanamid Co Reductive alkylation process
USRE26253E (en) * 1963-05-17 1967-08-15 And z-alkylamino-g-deoxytetracycline
US3526629A (en) * 1968-04-02 1970-09-01 American Cyanamid Co Beta-hydroxyethylpiperazinocarboxymethyl - 7 - dimethylamino - 6 - deoxy-6-demethyltetracycline
JPS5245716B1 (no) * 1970-07-10 1977-11-17
NL158172B (nl) * 1972-09-18 1978-10-16 Farmaceutici Italia Werkwijze voor het bereiden van tetracyclinederivaten met een substituent op de 7-plaats.
CN85101404A (zh) * 1985-05-16 1987-01-17 帝人株式会社 头孢菌素衍生物的生产过程
JPH0737433B2 (ja) * 1987-06-11 1995-04-26 協和醗酵工業株式会社 ７−アミノ−６−デメチル−６−デオキシテトラサイクリンの製造法
US4918208A (en) * 1987-07-28 1990-04-17 Nippon Kayaku Kabushiki Kaisha Process for producing 7-dimethylamino-6-demethyl-6-deoxytetracycline
US5202449A (en) * 1987-07-28 1993-04-13 Nippon Kayaku Kabushiki Kaisha Process for purifying 7-dimethylamino-6-demethyl-6-deoxytetracycline
JPH04235188A (ja) * 1990-06-19 1992-08-24 Takeda Chem Ind Ltd ペネム化合物の結晶、その製造方法および抗菌剤
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
DE4235133A1 (de) * 1992-10-19 1994-04-21 Bayer Ag Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
JP3623531B2 (ja) * 1993-06-07 2005-02-23 ビーエーエスエフ アクチェンゲゼルシャフト 結晶質ｌ−アスコルビン酸−２−燐酸エステルマグネシウム塩の製造法
DK1148049T3 (da) * 1995-07-17 2005-03-29 Warner Lambert Co Krystallinsk [R-(R*,R*)]-2-(4-fluorphenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- [(phenylamino)carbonyl]-1H-pyrrol-1-heptansyre-hemicalciumsalt (ATORVASTATIN)
DK1039908T3 (da) 1997-12-22 2004-05-03 Schering Corp Præparat med indhold af en molekylær dispersion med forøget biotilgængelighed
IE991013A1 (en) * 1998-12-01 2000-07-12 Atropos Ltd A Device
CL2004001884A1 (es) * 2003-08-04 2005-06-03 Pfizer Prod Inc Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
AR057649A1 (es) * 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
US20070093455A1 (en) * 2005-07-21 2007-04-26 Paul Abato 10-substituted tetracyclines and methods of use thereof
PT103661B (pt) 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina

Also Published As

Publication number Publication date
CA2722496C (en) 2014-06-10
ZA200906517B (en) 2010-09-29
WO2008102161A3 (en) 2009-01-08
WO2008102161A2 (en) 2008-08-28
MX340539B (es) 2016-07-13
PL2125705T3 (pl) 2017-02-28
BRPI0807319A2 (pt) 2017-05-02
BR122021000846B1 (pt) 2021-08-10
BRPI0807319B1 (pt) 2021-08-10
RU2009135403A (ru) 2011-03-27
DK2125705T3 (en) 2017-01-16
US8258327B2 (en) 2012-09-04
JP2010519247A (ja) 2010-06-03
WO2008102161A9 (en) 2008-11-13
PT103661B (pt) 2010-09-07
KR101391132B1 (ko) 2014-05-02
AU2008217619B2 (en) 2013-01-10
EP2125705B1 (en) 2016-10-12
ES2610434T3 (es) 2017-04-27
HUE033030T2 (hu) 2017-11-28
IL200544A0 (en) 2010-05-17
KR20100014520A (ko) 2010-02-10
CN101679218B (zh) 2013-10-30
RU2485095C2 (ru) 2013-06-20
US20130030195A1 (en) 2013-01-31
RU2013112021A (ru) 2014-09-27
JP2017039742A (ja) 2017-02-23
CA2835788C (en) 2018-03-27
MX2009008980A (es) 2009-11-11
RU2577331C2 (ru) 2016-03-20
US9416097B2 (en) 2016-08-16
PT103661A (pt) 2008-08-25
US20100286417A1 (en) 2010-11-11
JP2014169319A (ja) 2014-09-18
EP2125705A2 (en) 2009-12-02
CN101679218A (zh) 2010-03-24
NZ579626A (en) 2011-12-22
JP2019142882A (ja) 2019-08-29
AU2008217619A1 (en) 2008-08-28
CA2835788A1 (en) 2008-08-28
CA2722496A1 (en) 2008-08-28

Similar Documents

Publication Publication Date Title
NO20092960L (no) Krystallinsk minocycline base og framgangsmater for framstilling av denne
UA109883C2 (uk) Спосіб отримання сполук для застосування як інгібіторів sglt2
RU2014118950A (ru) Твердые формы нематоцидных сульфонамидов
NO20082382L (no) Fremgangsmater for fremstilling av krystallinsk rapamycin og for maling av krystallinitet av rapamycinforbindelser ved anvendelse av differentiell skanning-kalorimetri
IN2012DN03176A (no)
PH12017500437A1 (en) Methods for synthesis of graphene derivatives and functional materials from asphaltenes, graphene derivatives, 2d materials and applications of use
WO2009053854A3 (en) Polymorphs of dasatinib and process for preparation thereof
NZ734535A (en) Process of producing cycloalkylcarboxamido-indole compounds
PH12015501226A1 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same
WO2009139579A3 (ko) 비대칭 안트라센 유도체의 제조 및 이를 이용한 유기전계 발광 소자
CY1113184T1 (el) Μεθοδος για την παρασκευη θεραπευτικως πολυτιμων παραγωγων τριφαινυλβουτενιου
JP2012001634A5 (no)
NO20081621L (no) Tetrahydrokinoliner, syntese og intermediater
EA201000147A1 (ru) Способ выделения и очистки монтелукаста
WO2016089758A3 (en) Organo-1-oxa-4-azonium cyclohexane compounds
AU2010271717A8 (en) Process for producing crystals of polymorphic 2-(3-cyano-4-isobutyloxyphenyl) -4-methyl-5-thiazolecaboxylic acid by poor-solvent addition method
NO20080648L (no) Syntesemetoder med hoyt utbytte for fremstilling av organiske salter av strontium
RU2016134404A (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА α МОНОБЕНЗОАТА СОЕДИНЕНИЯ А, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И СОДЕРЖАЩАЯ ЕЕ ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
WO2007088558A3 (en) A process for purification of valsartan
RU2011143166A (ru) Новые кристаллические формы адефовира дипивоксила и способы его получения
NO20084414L (no) Fremgangsmate for fremstilling av heterocykliske derivater
WO2009022600A1 (ja) ヒドラジン化合物の製造方法、ならびにヒドラジン化合物の製造中間体およびその製造方法
WO2016100113A3 (en) Conjugates for assays for oxycodone and oxymorphone
Reddy et al. Iodine-catalyzed formation of aza-dienes: a novel synthesis of angularly fused hexahydropyrano-and furo [3, 2-c] quinoline derivatives
DK1591445T3 (da) Fremgangsmåde til fremstilling af krystalform I af cabergolin og solvater deraf

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: HOVIONE SCIENTIA LIMITED, IE

FC2A Withdrawal, rejection or dismissal of laid open patent application